on Trend Innovations Holding Inc. (NASDAQ:TREN)
Avant Technologies and Ainnova Finalize Retinal Camera Prototype
Avant Technologies Inc. and Ainnova Tech, Inc. have announced the final stages of their automated retinal camera prototype. This low-cost camera automatically captures and uploads images to Ainnova's Vision AI software platform, generating risk reports swiftly. The innovative device is poised to break market barriers due to its affordability.
Vinicio Vargas, Ainnova's CEO, highlighted the camera's integration with the Vision AI platform. The system aims to accelerate patient referrals and expand disease prevention beyond diabetes to include cardiovascular and other conditions.
Ainnova's Vision AI platform identifies early markers of diseases like diabetic retinopathy and cardiovascular issues using eye imaging data. Partnered under Ai-nova Acquisition Corp., Avant and Ainnova are developing this exclusive camera, enhancing their healthcare technology offerings.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Trend Innovations Holding Inc. news